Atlas Trials

Safety, Reactogenicity, and Immunogenicity Study of a Lyophilized COVID-19 mRNA Vaccine

Clinical trial NCT05366296 · WITHDRAWN

Trial details

NCT number
NCT05366296
Sponsor
Wuhan Recogen Biotechnology Co., Ltd.
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
COVID-19 Pandemic
Start date
2022-07-01
Primary completion
2022-09-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.